Cell death mechanisms in multiple system atrophy

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 9, 1998, Pages 814-821

  Probst Cousin, Stefan ^a   Rickert, Christian H ^b   Schmid, Kurt W ^c   Gullotta, Filippo ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Apoptosis; Cell death; Multiple system atrophy; Neurodegenerative diseases; Pathogenesis; Programmed cell death; TUNEL

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL INCLUSION; CELL LOSS; DEGENERATIVE DISEASE; DEMYELINATION; DNA NICK TRANSLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE CELL; NERVE DEGENERATION; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHY DRAGER SYNDROME;

EID: 0031689816     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199809000-00002     Document Type: Article

References (55)

1. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: A review of 203 pathologically proven cases. Movement Disorders 1997;12:133-47
2. Quinn NP. Multiple system atrophy. In: Marsden CD, Fahn S, eds. Movement disorders 3. London: Butterworths-Heinemann, 1994; 262-81
3. Quinn NP. Multiple system atrophy - The nature of the beast. J Neurol Neurosurg Psychiatry 1989;(special suppl):78-89
4. Quinn NP, Marsden CD. The motor disorder of multiple system atrophy. J Neurol Neurosurg Psychiatry 1993;56:1239-42
5. Déjérine J, Thomas A. L'atrophie olivo-ponto-cérébelleuse. Nouvelle Iconographie de la Salpêtriére 1900;13:330-70
6. Daniel SE. The neuropathology and neurochemistry of multiple system atrophy. In: Bannister R, Mathias CJ, eds. Autonomie failure: A textbook of disorders of the autonomie nervous system 3rd ed. Oxford: Oxford University Press, 1992;564-84
7. Oppenheimer D. Neuropathology of progressive autonomie failure. In: Bannister R, ed. Autonomic failure: A textbook of clinical disorders of the autonomie nervous system. Oxford: Oxford University Press, 1983;267-83
8. Lowe J, Lennox G, Leigh PN. Disorders of movement and system degenerations. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology 6th ed, vol II. London: Arnold, 1997;281-366
9. Papp MI, Khan JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100
10. Papp MI, Lantos PL. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 1992;107:172-82
11. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-43
12. Lantos PL, Papp MI. Cellular pathology of multiple system atrophy: A review. J Neurol Neurosurg Psychiatry 1994;57:129-33
13. Probst-Cousin S, Bergmann M, Kuchelmeister K, Schröder R, Schmid KW. Ubiquitin-positive inclusions in different types of multiple system atrophy: Distribution and specificity. Pathol Res Pract 1996;192:453-61
14. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57
15. Wyllie AH. Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 1993;67:205-8
16. Vaux DL. Review: Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 1993;90:786-89
17. Lo AC, Houenou J, Oppenheim RW. Apoptosis in the nervous system: Morphological features, methods, pathology, and prevention. Arch Histol Cytol 1995;58:139-49
18. Migheli A, Cavalla P, Marino S, Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol 1994;53:606-16
19. Troncoso JC, Sukhov RR, Kawas CH, Koliatsos VE. In situ end labeling of dying cortical neurons in normal aging and in Alzheimer's disease: Correlations with senile plaques and disease progression. J Neuropathol Exp Neurol 1996;55:1134-42
20. Lassmann H, Bancher C, Breitschopf H, et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995;89:35-41
21. Y and nick-end labeling are positive in spinal motor neurons in amytrophic lateral sclerosis. Acta Neuropathol 1994;88: 207-11
22. Cotman CW, Su JH. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathology 1996;6:493-506
23. Kreutzberg GW, Blakemore WF, Graeber MB. Cellular pathology of the central nervous system. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology 6th ed, vol I. London: Arnold, 1997; 85-156
24. Poirier J, ed. Neuromethods, Vol. 29: Apoptosis techniques and protocols. Totowa: Humana Press, 1997
25. Kordek R, Hironishi M, Liberski PP, Yanagihara R, Gajdusek DC. Apoptosis in glial tumors as determined by in situ nonradioactive labeling of DNA breaks. Acta Neuropathol 1996;91:112-16
26. Skoff RP. Programmed cell death in the dysmyelinating mutants. Brain Pathology 1995;5:283-88
27. Macaya A, Munell F, Gubits RM, Burke RE. Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc Natl Acad Sci USA 1994;91:8117-21
28. Adle-Biassette H, Levy Y, Colombel M et al. Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol 1995;21: 218-27
29. Chrétien F, Bélec L, Hilton DA, et al. Review. Herpes simplex virus type 1 encephalitis in acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol 1996;22:394-404
30. Sgonc R, Wick G. Methods for the detection of apoptosis. Int Arch Allergy Immunol 1994;105:327-32
31. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biology 1992;119:493-501
32. Probst-Cousin S, Rickert CH, Gullotta F. On the significance of apoptosis in multiple system atrophy and related disorders [abstract]. Mov Disorders 1997;12:829
33. Appel SH. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinsonism, and Alzheimer disease. Ann Neurol 1981;10:499-505
34. Lipton SA, Rosenberg PA. Excitatory aminoacids as a final common pathway for neurologic disorders. New Engl J Med 1994;330: 613-22
35. Olanow CW. A radical hypothesis for neurodegeneration. TINS 1993;16:439-44
36. Appel SH, Smith RG, Engelhardt JI, Stefani E. Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci 1993;118: 169-74
37. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurode-generative disorders. Science 1993;262:689-95
38. Hedreen JC, Portera C, Price DL, Koliatsos VE. Patterns of TUNEL labeling and non-random fragmentation in Huntington disease. Soc Neurosci Abstr 1994;20:250
39. Su JH, Anderson AJ, Cummings BJ, Cotman CW. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 1994;5:2529-33
40. Kösel S, Egensperger R, von Eitzen U, Mehraein P, Braeber MB. No evidence for a significant contribution of apoptosis to cell death in Parkinson's disease [abstract]. Clin Neuropathol 1996;15:279
41. Barres BA, Raff MC. Control of oligodendrocyte number in the developing rat optic nerve. Neuron 1994;12:935-42
42. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996;6:259-74
43. Li GL, Brodin G. Farooque M, et al. Apoptosis and expression of bcl-2 after compression trauma to rat spinal cord. J Neuropathol Exp Neurol 1996;55:280-89
44. Seto K, Abe M, Ohya O, et al. A rat model of HTLV-I infection: Development of chronic progressive myeloneuropathy in seropositive WKAH rats and related apoptosis. Acta Neuropathol 1995;89: 483-90
45. Lantos PL. Cellular and molecular pathology of multiple system atrophy: A review and recent developments. Brain Pathol 1997;7: 1293-97
46. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-36
47. Farlie PG, Dringen R, Rees SM, Kannourakis G, Bernard O. Bcl-2 transgene expression can protect neurons against developmental and induced cell death. PNAS USA 1995;92:4397-401
48. Novack DV, Korsmeyer SJ. Bcl-2 protein expression during murine development. Am J Pathol 1994;145:61-73
49. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ. Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 1994;120:301-11
50. Nakasu S, Nakasu Y, Nioka H, Nakajima M, Handa J. Bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol 1994;88:520-26
51. Schiffer D, Cavalla P, Migheli A, Giordana MT, Chiado-Piat L. Bcl-2 distribution in neuroepithelial tumors: An immunohistochemical study. J Neurooncol 1996;27:101-9
52. Hara A, Hirose Y, Wang A, Yoshimi N, Tanaka T, Mon H. Localization of bax and bcl-2 proteins, regulators of programmed cell death, in the human central nervous system. Virchows Arch 1996;429:249-53
53. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am J Pathol 1994;145: 1323-36
54. Su JH, Deng G, Cotman CW. Bax protein expression is increased in Alzheimer's brain: Correlations with DNA damage, bcl-2 expression, and brain pathology. J Neuropathol Exp Neurol 1997;56: 86-93
55. Johnson EM, Deckwerth TL, Deshmukh M. Neuronal death in developmental models: Possible implications in neuropathology. Brain Pathol 1996;6:397-409